Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 197

1.

Aspergillus endocarditis diagnosed by fungemia plus serum antigen testing.

Hatlen TJ, Filler SG, Bayer A, Shah S, Shodhan S, Van TT.

Med Mycol Case Rep. 2018 Oct 25;23:1-3. doi: 10.1016/j.mmcr.2018.10.004. eCollection 2019 Mar.

2.

Protective immunity in recurrent Staphylococcus aureus infection reflects localized immune signatures and macrophage-conferred memory.

Chan LC, Rossetti M, Miller LS, Filler SG, Johnson CW, Lee HK, Wang H, Gjertson D, Fowler VG Jr, Reed EF, Yeaman MR; MRSA Systems Immunobiology Group.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11111-E11119. doi: 10.1073/pnas.1808353115. Epub 2018 Oct 8.

PMID:
30297395
3.

Proteome Analysis Reveals the Conidial Surface Protein CcpA Essential for Virulence of the Pathogenic Fungus Aspergillus fumigatus.

Voltersen V, Blango MG, Herrmann S, Schmidt F, Heinekamp T, Strassburger M, Krüger T, Bacher P, Lother J, Weiss E, Hünniger K, Liu H, Hortschansky P, Scheffold A, Löffler J, Krappmann S, Nietzsche S, Kurzai O, Einsele H, Kniemeyer O, Filler SG, Reichard U, Brakhage AA.

MBio. 2018 Oct 2;9(5). pii: e01557-18. doi: 10.1128/mBio.01557-18.

4.

A possible role for fumagillin in cellular damage during host infection by Aspergillus fumigatus.

Guruceaga X, Ezpeleta G, Mayayo E, Sueiro-Olivares M, Abad-Diaz-De-Cerio A, Aguirre Urízar JM, Liu HG, Wiemann P, Bok JW, Filler SG, Keller NP, Hernando FL, Ramirez-Garcia A, Rementeria A.

Virulence. 2018;9(1):1548-1561. doi: 10.1080/21505594.2018.1526528.

5.

Targeted enrichment outperforms other enrichment techniques and enables more multi-species RNA-Seq analyses.

Chung M, Teigen L, Liu H, Libro S, Shetty A, Kumar N, Zhao X, Bromley RE, Tallon LJ, Sadzewicz L, Fraser CM, Rasko DA, Filler SG, Foster JM, Michalski ML, Bruno VM, Dunning Hotopp JC.

Sci Rep. 2018 Sep 6;8(1):13377. doi: 10.1038/s41598-018-31420-7.

6.

Inhibition of EGFR Signaling Protects from Mucormycosis.

Watkins TN, Gebremariam T, Swidergall M, Shetty AC, Graf KT, Alqarihi A, Alkhazraji S, Alsaadi AI, Edwards VL, Filler SG, Ibrahim AS, Bruno VM.

MBio. 2018 Aug 14;9(4). pii: e01384-18. doi: 10.1128/mBio.01384-18.

7.

Intersection of phosphate transport, oxidative stress and TOR signalling in Candida albicans virulence.

Liu NN, Uppuluri P, Broggi A, Besold A, Ryman K, Kambara H, Solis N, Lorenz V, Qi W, Acosta-Zaldívar M, Emami SN, Bao B, An D, Bonilla FA, Sola-Visner M, Filler SG, Luo HR, Engström Y, Ljungdahl PO, Culotta VC, Zanoni I, Lopez-Ribot JL, Köhler JR.

PLoS Pathog. 2018 Jul 30;14(7):e1007076. doi: 10.1371/journal.ppat.1007076. eCollection 2018 Jul.

8.

Functional convergence of gliP and aspf1 in Aspergillus fumigatus pathogenicity.

Liu H, Xu W, Solis NV, Woolford C, Mitchell AP, Filler SG.

Virulence. 2018;9(1):1062-1073. doi: 10.1080/21505594.2018.1482182.

9.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

10.

Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.

Uppuluri P, Singh S, Alqarihi A, Schmidt CS, Hennessey JP Jr, Yeaman MR, Filler SG, Edwards JE, Ibrahim AS.

Front Immunol. 2018 Jun 15;9:1349. doi: 10.3389/fimmu.2018.01349. eCollection 2018.

11.

Author Correction: EphA2 is an epithelial cell pattern recognition receptor for fungal β-glucans.

Swidergall M, Solis NV, Lionakis MS, Filler SG.

Nat Microbiol. 2018 Sep;3(9):1074. doi: 10.1038/s41564-018-0188-5.

PMID:
29895959
12.

Candida albicans cannot acquire sufficient ethanolamine from the host to support virulence in the absence of de novo phosphatidylethanolamine synthesis.

Davis SE, Tams RN, Solis N, Wagner AS, Chen T, Jackson JW, Hasim S, Montedonico AE, Dinsmore J, Sparer TE, Filler SG, Reynolds TB.

Infect Immun. 2018 Jun 4. pii: IAI.00815-17. doi: 10.1128/IAI.00815-17. [Epub ahead of print]

PMID:
29866908
13.

The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.

Uppuluri P, Lin L, Alqarihi A, Luo G, Youssef EG, Alkhazraji S, Yount NY, Ibrahim BA, Bolaris MA, Edwards JE Jr, Swidergall M, Filler SG, Yeaman MR, Ibrahim AS.

PLoS Pathog. 2018 May 10;14(5):e1007056. doi: 10.1371/journal.ppat.1007056. eCollection 2018 May.

14.

Rapid Phenotypic and Genotypic Diversification After Exposure to the Oral Host Niche in Candida albicans.

Forche A, Cromie G, Gerstein AC, Solis NV, Pisithkul T, Srifa W, Jeffery E, Abbey D, Filler SG, Dudley AM, Berman J.

Genetics. 2018 Jul;209(3):725-741. doi: 10.1534/genetics.118.301019. Epub 2018 May 3.

PMID:
29724862
15.

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.

Edwards JE Jr, Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J, Holmberg T, Cooke MT, Hoover K, Edwards L, Jacobs M, Sussman S, Augenbraun M, Drusano M, Yeaman MR, Ibrahim AS, Filler SG, Hennessey JP Jr.

Clin Infect Dis. 2018 Jun 1;66(12):1928-1936. doi: 10.1093/cid/ciy185.

PMID:
29697768
16.

Candida albicans White-Opaque Switching Influences Virulence but Not Mating during Oropharyngeal Candidiasis.

Solis NV, Park YN, Swidergall M, Daniels KJ, Filler SG, Soll DR.

Infect Immun. 2018 May 22;86(6). pii: e00774-17. doi: 10.1128/IAI.00774-17. Print 2018 Jun.

17.

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis.

Persichino JG, Can AD, Van TT, Matthews MN, Filler SG.

Med Mycol Case Rep. 2018 Mar 6;21:12-15. doi: 10.1016/j.mmcr.2018.03.004. eCollection 2018 Sep.

18.

Publisher Correction: EphA2 is an epithelial cell pattern recognition receptor for fungal β-glucans.

Swidergall M, Solis NV, Lionakis MS, Filler SG.

Nat Microbiol. 2018 Mar;3(3):387. doi: 10.1038/s41564-017-0100-8.

PMID:
29440749
19.

Comparative transcriptomics of Aspergillus fumigatus strains upon exposure to human airway epithelial cells.

Watkins TN, Liu H, Chung M, Hazen TH, Dunning Hotopp JC, Filler SG, Bruno VM.

Microb Genom. 2018 Jan 18. doi: 10.1099/mgen.0.000154. [Epub ahead of print]

20.

Inhibiting mitochondrial phosphate transport as an unexploited antifungal strategy.

McLellan CA, Vincent BM, Solis NV, Lancaster AK, Sullivan LB, Hartland CL, Youngsaye W, Filler SG, Whitesell L, Lindquist S.

Nat Chem Biol. 2018 Feb;14(2):135-141. doi: 10.1038/nchembio.2534. Epub 2017 Dec 11.

Supplemental Content

Loading ...
Support Center